Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NovaBay Pharmaceuticals has announced the closing of its initial public offering of five million shares of its common stock at a price of $4 per share.
Subscribe to our email newsletter
NovaBay has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering (IPO) price to cover over-allotments, if any.
Dundee Securities acted as the sole book runner for the IPO, with Desjardins Securities as co-lead manager. The shares were offered in Canada by an underwriting syndicate co-led by Dundee Securities, Desjardins Securities and Blackmont Capital and in the US by Dundee Securities and Dawson James Securities.